Snehashish Sarkar
CIK: 0001951379
Associated companies
Transaction History
| ACH | ▼ Sell | Tax Withholding | 4,336 | $30K | 5/15/2025 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,977 | $20K | 3/20/2025 | View on chart |
| ACH | ▲ Buy | Grant | 59,013 | $0 | 3/3/2025 | View on chart |
| ACH | ▼ Sell | Open Market | 2,055 | $25K | 11/18/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,196 | $15K | 11/15/2024 | View on chart |
| ACH | ▼ Sell | Open Market | 9,980 | $173K | 6/4/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 4,322 | $85K | 5/15/2024 | View on chart |
| ACH | ▲ Buy | Grant | 14,205 | $0 | 3/1/2024 | View on chart |
| ACH | ▲ Buy | Grant | 555 | $9K | 12/29/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,159 | $21K | 11/15/2023 | View on chart |
| ACH | ▲ Buy | Grant | 13,624 | $0 | 7/27/2023 | View on chart |
| ACH | ▲ Buy | Grant | 739 | $12K | 6/30/2023 | View on chart |
| ACH | ▲ Buy | Grant | 35,622 | $0 | 3/1/2023 | View on chart |
| ACH | ▲ Buy | Grant | 9,853 | $0 | 11/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.